CARBAMYLATED HEMOGLOBIN, UREA KINETIC MODELING AND ADEQUACY OF DIALYSIS IN HEMODIALYSIS-PATIENTS

被引:31
作者
KWAN, JTC
CARR, EC
NEAL, AD
BURDON, J
RAFTERY, MJ
MARSH, FP
BARRON, JL
BENDING, MR
机构
[1] ST HELIER HOSP, DEPT CLIN CHEM, CARSHALTON SM5 1AA, SURREY, ENGLAND
[2] ST HELIER HOSP, DEPT NEPHROL, CARSHALTON SM5 1AA, SURREY, ENGLAND
[3] COBE LABS LTD, GLOUCESTER, ENGLAND
关键词
ADEQUACY OF DIALYSIS; CARBAMYLATED HEMOGLOBIN; HEMODIALYSIS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; UREA KINETIC MODELING;
D O I
10.1093/ndt/6.1.38
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Urea kinetic modelling (UKM) has increasingly been used for assessing adequacy of dialysis and protein nutritional status of dialysis patients. Using a precise HPLC method we developed, we measured carbamylated haemoglobin (CarHb) values in 20 stable twice-weekly dialysed patients and attempted to correlate their CarHb values with their UKM-derived indices. Based on these indices, 11 patients were found to have been adequately dialysed with sufficient protein intake, three patients were adequately dialysed but malnourished and six patients were under-dialysed. Estimated dietary protein intake correlated poorly with calculated daily protein catabolic rate in our patients. CarHb values were found to correlate strongly with the time-averaged urea concentrations, suggesting that CarHb might be a time-integrated urea-derived index. Those adequately dialysed patients have a mean (SD) CarHb value of 142 (29) mu-g CV/gHb against the under-dialysed patients, 197 (30) mu-g CV/gHb (t-test, P = 0.002). We suggest that a CarHb value < 175-mu-g CV/gHb may represent satisfactory uraemic exposure, whereas CarHb value > 175-mu-g CV/gHb is undesirable.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 13 条
  • [1] HEMOGLOBIN CARBAMYLATION IN UREMIA
    FLUCKIGER, R
    HARMON, W
    MEIER, W
    LOO, S
    GABBAY, KH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (14) : 823 - 827
  • [2] A MECHANISTIC ANALYSIS OF THE NATIONAL COOPERATIVE DIALYSIS STUDY (NCDS)
    GOTCH, FA
    SARGENT, JA
    [J]. KIDNEY INTERNATIONAL, 1985, 28 (03) : 526 - 534
  • [3] GOTCH FA, 1976, KIDNEY, P1643
  • [4] HARTER HR, 1983, KIDNEY INT S13, V23, pS107
  • [5] KWAN JTC, 1990, CLIN CHEM, V36, P607
  • [6] EFFECT OF THE HEMODIALYSIS PRESCRIPTION ON PATIENT MORBIDITY - REPORT FROM THE NATIONAL COOPERATIVE DIALYSIS STUDY
    LOWRIE, EG
    LAIRD, NM
    PARKER, TF
    SARGENT, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (20) : 1176 - 1181
  • [7] MANNING JM, 1973, J LAB CLIN MED, V81, P941
  • [8] SARGENT JA, 1975, KIDNEY INT, V7, pS35
  • [9] SARGENT JA, 1983, KIDNEY INT, pS19
  • [10] SARGENT JA, 1989, REPLACEMENT RENAL FU, P87